85
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Hydroxypropyl-β-cyclodextrin functionalized calcium carbonate microparticles as a potential carrier for enhancing oral delivery of water-insoluble drugs

, , , , &
Pages 3291-3302 | Published online: 30 Apr 2015

References

  • LipinskiCALombardoFDominyBWFeeneyPJExperimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdv Drug Deliv Rev20014632611259830
  • SinghSParikhTSandhuHKSupersolubilization and amorphization of a model basic drug, haloperidol, by interaction with weak acidsPharm Res2013301561157323430485
  • BroughCWilliamsROAmorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug deliveryInt J Pharm201345315716623751341
  • KawabataYWadaKNakataniMYamadaSOnoueSFormulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applicationsInt J Pharm201142011021884771
  • MüllerRHJacobsCKayserONanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the futureAdv Drug Deliv Rev20114731911251242
  • Merisko-LiversidgeELiversidgeGGNanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technologyAdv Drug Deliv Rev20116342744021223990
  • VasconcelosTSarmentoBCostaPSolid dispersions as strategy to improve oral bioavailability of poor water soluble drugsDrug Discov Today2007121068107518061887
  • ThomasMJSlipperIWalunjAInclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticlesInt J Pharm201038727227720025947
  • WangSOrdered mesoporous materials for drug deliveryMicroporous Mesoporous Mater200911719
  • KuangDBrezesinskiTSmarslyBHierarchical porous silica materials with a trimodal pore system using surfactant templatesJ Am Chem Soc2004126105341053515327299
  • WaniAMuthuswamyESavithraGHMaoGBrockSOupickýDSurface functionalization of mesoporous silica nanoparticles controls loading and release behavior of mitoxantronePharm Res2012292407241822555380
  • ZhangYWangJBaiXJiangTZhangQWangSMesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugsMol Pharm2012950551322217205
  • KinnariPMäkiläEHeikkiläTSalonenJHirvonenJSantosHAComparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazoleInt J Pharm201141414815621601623
  • ParakhonskiyBVHaaseAAntoliniRSub-micrometer vaterite containers: synthesis, substance loading, and releaseAngew Chem Int Ed Engl2012511195119722375283
  • PreisigDHaidDVarumFJDrug loading into porous calcium carbonate microparticles by solvent evaporationEur J Pharm Biopharm20148754855824568926
  • SvenskayaYParakhonskiyBHaaseAAnticancer drug delivery system based on calcium carbonate particles loaded with a photosensitizerBiophys Chem2013182111523932207
  • KurapatiaRRaichurAMComposite cyclodextrin–calcium carbonate porous microparticles and modified multilayer capsules: novel carriers for encapsulation of hydrophobic drugsJ Mater Chem B2013131753184
  • Kassler-TaubKLittlejohnTElliottWRuddyTAdlerEComparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study InvestigatorsAm J Hypertens1998114454539607383
  • FaresMMSalemMSKhanfarMInulin and poly(acrylic acid) grafted inulin for dissolution enhancement and preliminary controlled release of poorly water-soluble Irbesartan drugInt J Pharm201141020621121421037
  • StevensWJLebeauKMertensMVan TendelooGCoolPVansantEFInvestigation of the morphology of the mesoporous SBA-16 and SBA-15 materialsJ Phys Chem B20061109183918716671732
  • HiguchiTConnorsKAPhase-solubility techniquesAdv Anal Chem Instrum19654117212
  • KrukMAccess to ultralarge-pore ordered mesoporous materials through selection of surfactant/swelling-agent micellar templatesAcc Chem Res2012451678168722931347
  • ShenSCNgWKChiaLHuJTanRBPhysical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle sizeInt J Pharm201141018819521419202
  • GuoZLiuXMMaLEffects of particle morphology, pore size and surface coating of mesoporous silica on naproxen dissolution rate enhancementColloids Surf B Biointerfaces201310122823523010024
  • ZhangPForsgrenJStrømmeMStabilisation of amorphous ibuprofen in Upsalite, a mesoporous magnesium carbonate, as an approach to increasing the aqueous solubility of poorly soluble drugsInt J Pharm201447218519124950364
  • JacksonCLMcKennaGBVitrification and crystallization of organic liquids confined to nanoscale poresChem Mat1996821282137
  • LiuMCaoWSunYHeZPreparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-b-cyclodextrinInt J Pharm201447715916625455768
  • ZoellerTDressmanJBKleinSApplication of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditionsInt J Pharm201243017618322531855
  • Vallet-RegiMBalasFArcosDMesoporous materials for drug deliveryAngew Chem Int Ed Engl2007467548755817854012
  • Vallet-RegiMNanostructured mesoporous silica matrices in nanomedicineJ Intern Med2010267224320059642
  • DokoumetzidisAMacherasPA century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification systemInt J Pharm200632111116920290